ライフサイエンスコーパス: catheterization laboratory

1 dy supports the routine use of RADPAD in the catheterization laboratory.

2 rgery and by subendocardial injection in the catheterization laboratory.

3 mergency room or later administration in the catheterization laboratory.

4 fraction <40% had dobutamine infusion in the catheterization laboratory.

5 to inhaled nitric oxide (iNO) in the cardiac catheterization laboratory.

6 All defects were closed in the catheterization laboratory.

7 facilitates the reduction of exposure in the catheterization laboratory.

8 ction on-line of myocardial viability in the catheterization laboratory.

9 in participants ascertained via the cardiac catheterization laboratory.

10 he potential of this approach in the cardiac catheterization laboratory.

11 results have important implications for the catheterization laboratory.

12 patients, in 2 of the 4 before they left the catheterization laboratory.

13 ry artery disease encountered in the cardiac catheterization laboratory.

14 elpful in the diagnosis of CP in the cardiac catheterization laboratory.

15 rdiopulmonary bypass or interventions in the catheterization laboratory.

16 ement of CI-AKI as it applies to the cardiac catheterization laboratory.

17 ot be recommended for decision making in the catheterization laboratory.

18 patients prior to activation of the cardiac catheterization laboratory.

19 ion are not readily available in the cardiac catheterization laboratory.

20 %) had a measurable pressure gradient in the catheterization laboratory.

21 are transferable to actual procedures in the catheterization laboratory.

22 s as to why we still need BMS in our cardiac catheterization laboratory.

23 ly performed post-operatively in the cardiac catheterization laboratory.

24 Gs consistent with STEMI were triaged to the catheterization laboratory.

25 ducing a second anticoagulant in the cardiac catheterization laboratory.

26 se patients were successfully treated in the catheterization laboratory.

27 and most U.S. hospitals do not have cardiac catheterization laboratories.

28 for 10 years; 3) the hospital had a cardiac catheterization laboratory; 4) costs of night call for t

29 he median OxPL/apoB presented to the cardiac catheterization laboratory a mean of 3.9 years earlier (

30 Use of FFR in the catheterization laboratory accurately identifies which l

31 y care processes increased after prehospital catheterization laboratory activation (62%-91%; P<0.001)

32 levation myocardial infarction diagnosis and catheterization laboratory activation (door-to-activatio

33 PCI hospitals agreed to provide single-call catheterization laboratory activation by emergency medic

34 point was the time from hospital arrival to catheterization laboratory activation by the emergency d

35 mmunity and rural hospitals with pretransfer catheterization laboratory activation for percutaneous c

36 The frequency of false-positive cardiac catheterization laboratory activation for suspected STEM

37 ed data on the frequency of "false-positive" catheterization laboratory activation in patients underg

38 Prevalence of false-positive catheterization laboratory activation in patients with s

39 ), a first medical contact to device time to catheterization laboratory activation of </=20 minutes (

40 l infarction networks focused on prehospital catheterization laboratory activation, single call trans

41 to increased rates of false-positive cardiac catheterization laboratory activation, unnecessary risks

42 consider the consequences of false-positive catheterization laboratory activation.

43 ography, and higher residual gradient in the catheterization laboratory after ASA (all P<0.05).

44 al electrocardiograms (ECGs) to activate the catheterization laboratory, allowing emergency physician

45 tricular fibrillation (VT/VF) in the cardiac catheterization laboratory among patients undergoing pri

46 te was lower at facilities with small-volume catheterization laboratories and was not associated with

47 gency department physician activation of the catheterization laboratory and (2) immediate transfer of

48 iac ARIA 1A locations (hospital with cardiac catheterization laboratory and all aftercare within 1 ho

49 Clopidogrel (300 mg) was administered in the catheterization laboratory and followed by 75 mg daily.

50 gency department physician activation of the catheterization laboratory and immediate transfer of the

51 Combining the tools of the catheterization laboratory and operating room greatly en

52 The residual LVOT gradient in the catheterization laboratory and peak CK leak after ASA ar

53 ference between the patient's arrival at the catheterization laboratory and the patient's final angio

54 infarction, including time of arrival in the catheterization laboratory and time of first balloon inf

55 chemia will be the gatekeeper to the cardiac catheterization laboratory and will transform the world

56 hat had weak or no regulation of new cardiac catheterization laboratories, and in wealthier and large

57 received anesthesia in the pediatric cardiac catheterization laboratory, and 51 were deeply sedated i

58 llowing emergency physicians to activate the catheterization laboratory, and substantial interdiscipl

59 gency medical systems, emergency department, catheterization laboratory, and transfer.

60 onal procedures in the electrophysiology and catheterization laboratory are rapidly advancing.

61 nt of coronary artery disease in the cardiac catheterization laboratory are reviewed.

62 e (25th-75th percentiles) from ED arrival to catheterization laboratory arrival was 30 (20-41) minute

63 analyses, when there was an existing cardiac catheterization laboratory at a hospital with > or = 200

64 We included all patients presenting to the catheterization laboratory at our institution after PMI

65 od predicts periprocedural MI in the cardiac catheterization laboratory before it occurs.

66 spirin point-of-care assays were used in the catheterization laboratory before stent implantation and

67 unctional LVOT conduit were evaluated in the catheterization laboratory between December 2008 and Aug

68 ty improvement activity performed in cardiac catheterization laboratories, but best practices for cas

69 exists about whether hospitals with cardiac catheterization laboratories, but without onsite cardiac

70 r of the patient to an immediately available catheterization laboratory by an in-house transfer team

71 hospital ECGs, prehospital activation of the catheterization laboratory, bypassing geographically clo

72 al treatment, or nothing) recommended by the catheterization laboratory cardiologist for patients und

73 e found to have coronary artery disease, the catheterization laboratory cardiologist was the final so

74 Catheterization laboratory cardiologists in hospitals wi

75 , Reporting, and Tracking System for Cardiac Catheterization Laboratories (CART-CL) program.

76 The end points included patency rates on catheterization laboratory (cath lab) arrival, technical

77 sfer from the STEMI referral hospital to the catheterization laboratory (cath lab) at the STEMI recei

78 copic exposure rates in contemporary cardiac catheterization laboratories (CCL).

79 ent elevation myocardial infarction, cardiac catheterization laboratory (CCL) activation by emergency

80 vel protocol of early transport to a cardiac catheterization laboratory (CCL) for extracorporeal life

81 Rapid activation of a cardiac catheterization laboratory (CCL) has reduced door-to-bal

82 The procedural success rate without major catheterization laboratory complications was similar in

83 edian, $13,809), $6,515 of which represented catheterization laboratory costs.

84 The use of these microbubbles in the cardiac catheterization laboratory could, therefore, provide fur

85 510) with ISR were identified using cardiac catheterization laboratory data.

86 A cardiac catheterization laboratory database used by 19 hospitals

87 ronary heart disease from coronary units and catheterization laboratories, direct mail to age-eligibl

88 left ventricular hemodynamics in the cardiac catheterization laboratory during EECP.

89 ation) and those transported directly to the catheterization laboratory (ED bypass).

90 Particular adaptations to the cardiac catheterization laboratory environment are required to a

91 varying assumptions about whether a cardiac catheterization laboratory exists, whether services are

92 and pressure can be obtained in the cardiac catheterization laboratory, facilitating physiologically

93 sociated with hospital size, remoteness, and catheterization laboratory facilities.

94 Subjects were brought back to the catheterization laboratory for guide wire crossing and a

95 ecutive patients referred to the Mayo Clinic catheterization laboratory for hemodynamic assessment be

96 tcomes in patients presenting to the cardiac catheterization laboratory for myocardial infarction sus

97 he integration of coronary physiology in the catheterization laboratory for optimal patient outcomes.

98 32 patients representing 13,061 trips to the catheterization laboratory for percutaneous transluminal

99 g for patient triage directly to the cardiac catheterization laboratory from the field.

100 ith bivalirudin monotherapy or bivalirudin + catheterization laboratory GPI (p = 0.02).

101 f coronary artery disease in patients in the catheterization laboratory has become increasingly impor

102 Development of the "all-digital" cardiac catheterization laboratory has been slowed by substantia

103 e use of invasive coronary physiology in the catheterization laboratory has demonstrated favorable ou

104 ambulance (ambulance group, n=127) or in the catheterization laboratory (hospital group, n=129).

105 s classified according to PCI center status (catheterization laboratory immediately accessible 24/7).

106 data on all CAs and PCIs performed in the 36 catheterization laboratories in the Greater Paris Area,

107 s data from approximately 85% of the cardiac catheterization laboratories in the United States.

108 In a high-volume cardiac catheterization laboratory in a large, nonuniversity tea

109 l process for developing an HOR in a cardiac catheterization laboratory in a VA designated for comple

110 In the catheterization laboratory, intravascular imaging provid

111 department physician to activate the cardiac catheterization laboratory is a key strategy to reduce d

112 X-ray use in the catheterization laboratory is guided by the principle of

113 e incidence of CIHB in the pediatric cardiac catheterization laboratory is low at 2.2%.

114 in a large number of patients in the cardiac catheterization laboratory, is increasingly used for dec

115 ography or deferred for selective use in the catheterization laboratory just prior to angioplasty.

116 es from intensive care units for the cardiac catheterization laboratory (lower by 0.44 percentage poi

117 site visit consisting of a National Chief of Catheterization Laboratory Managers, a cardiac surgeon,

118 ts with high-risk AMI at hospitals without a catheterization laboratory may have an improved outcome

119 department (ED) with direct transport to the catheterization laboratory may shorten reperfusion times

120 g emergency medicine physicians activate the catheterization laboratory (mean reduction in door-to-ba

121 = 346, 97%); single phone call activation of catheterization laboratory (N = 335, 92%); emergency dep

122 If a new cardiac catheterization laboratory needed to be built, costs wou

123 for selective administration in the cardiac catheterization laboratory only to patients undergoing p

124 number of clinicians are using a strategy of catheterization laboratory-only eptifibatide (an off-lab

125 A catheterization laboratory-only eptifibatide regimen is

126 We used optimal matching to link the use of catheterization laboratory-only eptifibatide with clinic

127 alysis, compared with bolus plus infusion, a catheterization laboratory-only regimen was associated w

128 Of these, a catheterization laboratory-only regimen was used in 4511

129 olus plus infusion with those treated with a catheterization laboratory-only regimen.

130 at the time of CABG performed in the hybrid catheterization laboratory/operating room.

131 be transferred to an intensive care unit, a catheterization laboratory or an operating room for furt

132 l procedures were performed within a cardiac catheterization laboratory or hybrid operating room unde

133 procedural predictors were total time in the catheterization laboratory or operating room, delivery c

134 The interventions did not increase catheterization laboratory or postprocedural complicatio

135 In the catheterization laboratory, physiologically significant

136 total occlusions are common in contemporary catheterization laboratory practice.

137 At hospitals with an existing cardiac catheterization laboratory, primary angioplasty for acut

138 is potentially applicable as a percutaneous catheterization laboratory procedure for the treatment o

139 Four-hundred consecutive patients undergoing catheterization laboratory procedures were randomly assi

140 The catheterization laboratory protocol provides a model to

141 Measurements of coronary physiology in the catheterization laboratory provide objective data that c

142 r of the patient to an immediately available catheterization laboratory reduce door-to-balloon time,

143 ach utilizes hospital facilities outside the catheterization laboratory, requiring additional time an

144 s, and scene departure to patient on cardiac catheterization laboratory table </=30 minutes.

145 e from scene departure to arrival on cardiac catheterization laboratory table of </=30 minutes were 1

146 and early and consistent availability of the catheterization laboratory team.

147 citation, and endotracheal intubation in the catheterization laboratory, their in-hospital and one-ye

148 ice transport from the field directly to the catheterization laboratory, thereby bypassing the emerge

149 In the catheterization laboratory three techniques can be used

150 on, LVOT gradient reduction after ASA in the catheterization laboratory to > or =25 mm Hg (OR, 5.5; P

151 nctional information that can be used in the catheterization laboratory to designate patients to the

152 the median time from arrival in the cardiac catheterization laboratory to first balloon was 27 minut

153 lar approach could be applied in the cardiac catheterization laboratory to protect reperfused myocard

154 in the ambulance) versus in-hospital (in the catheterization laboratory) treatment with ticagrelor.

155 ng staff in the emergency department and the catheterization laboratory use real-time data feedback (

156 ical measurements can be made in the cardiac catheterization laboratory using sensor-tipped guidewire

157 CART) program representing all 76 VA cardiac catheterization laboratories, we evaluated all patients

158 having the emergency department activate the catheterization laboratory while the patient is en route

159 nt 'Fontan' procedure to be completed in the catheterization laboratory with a covered stent.

160 ynamic measurements were made in the cardiac catheterization laboratory with a Swan-Ganz thermodiluti

161 hic examinations at baseline, acutely in the catheterization laboratory with ethanol injection and at

162 ty-nine patients were studied in the cardiac catheterization laboratory with simultaneous Doppler ech

163 4 minutes), expecting staff to arrive in the catheterization laboratory within 20 minutes after being

164 nd interventional studies in the Mayo Clinic catheterization laboratory within an eight week period i